Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.
about
A Novel Method and Its Application to Measuring Pathogen Decay in Bioaerosols from Patients with Respiratory DiseaseA human surfactant peptide-elastase inhibitor construct as a treatment for emphysema.Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting.Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosisProposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections.Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients.Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infectionPseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Detection of algD, oprL and exoA Genes by New Specific Primers as an Efficient, Rapid and Accurate Procedure for Direct Diagnosis of Pseudomonas aeruginosa Strains in Clinical Samples.Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting.Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.Discriminating typical and atypical cystic fibrosis-related bacteria by multiplex PNA-FISH.A set of PCRs for rapid identification and characterization of Pseudomonas syringae phylogroups.Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
P2860
Q28383536-485C5D97-3DCC-4FE7-A416-E2442F507D6BQ33934859-B22AC62C-A12C-49D8-B3D8-058BBE0B68FEQ34412265-1D4F88AF-4002-4EE4-8419-AC8FB3ED72A4Q34487493-DF8A9A12-C069-4C8C-9BBD-C6331345FA38Q35006748-47641D37-E500-4F6F-A6C5-A9E2619F8499Q35861377-19F01925-D3AD-4C9D-9699-F1091082E31FQ35875094-D779586B-9E8F-4F82-9A8E-F5CBA2A7C4BFQ36478351-EF349CD7-3761-438F-821A-9B420C870216Q37478266-0AD39319-21FC-416C-AB95-9291DEA9BE75Q40164055-C8325884-110A-417B-A2D3-D0881A55BE61Q40252432-8362BC23-8E51-473D-8D42-23259327C918Q41515510-8F8D6403-2DE7-4611-9997-367E35D116A8Q42089409-56B79000-2722-4A68-A273-46A72FAAD7F0Q42249115-792564E7-9760-42CC-9DA0-FD5A3F98BFF3Q42256090-A3359CF5-3A80-4784-8515-DFBD17FBA531Q45029608-5BAE4C89-F71F-43F7-9749-2858640967E2Q46495945-ABDDF450-21B3-4D71-B34F-DD2F11A3AD13Q46624763-DC6718B1-675E-4429-82B9-45A61D9405ACQ47103711-864297FE-7873-4363-BFF1-F9E3F9320598
P2860
Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@ast
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@en
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@nl
type
label
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@ast
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@en
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@nl
prefLabel
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@ast
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@en
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@nl
P2093
P2860
P50
P356
P1476
Low rates of Pseudomonas aerug ...... from cystic fibrosis patients.
@en
P2093
ACPinCF Investigators
Barbara R Rose
Colin Harbour
Guy B Marks
Kay A Ramsay
Keith Grimwood
Peter T P Bye
Philip J Robinson
Theo P Sloots
P2860
P304
P356
10.1128/JCM.00014-09
P407
P577
2009-03-04T00:00:00Z